Your browser doesn't support javascript.
loading
Real-world safety and efficacy of nivolumab for ≥ 2nd line treatment of metastatic renal cell carcinoma: A retrospective cohort study in Croatia, Hungary, and Malta.
Vrdoljak, Eduard; Magri, Claude; Gamulin, Marija; Boskovic, Lidija; Omrcen, Tomislav; Bajic, Zarko; Dienes, Tamas; Geczi, Lajos.
Afiliação
  • Vrdoljak E; Department of Oncology, University Hospital Split, School of Medicine, University of Split, Split, Croatia.
  • Magri C; Mater Dei Hospital, Triq Dun Karm, L-Imsida, Malta.
  • Gamulin M; Department of Oncology, University Hospital Center Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Boskovic L; Department of Oncology, University Hospital Split, School of Medicine, University of Split, Split, Croatia.
  • Omrcen T; Department of Oncology, University Hospital Split, School of Medicine, University of Split, Split, Croatia.
  • Bajic Z; Scientific unit Dr. Mirko Grmek, Psychiatric Hospital Sveti Ivan, Zagreb, Croatia.
  • Dienes T; National Institute of Oncology, Budapest, Hungary.
  • Geczi L; National Institute of Oncology, Budapest, Hungary.
Neoplasma ; 68(1): 208-215, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32940046
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Nivolumabe / Neoplasias Renais Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Imunológicos / Nivolumabe / Neoplasias Renais Idioma: En Ano de publicação: 2021 Tipo de documento: Article